Literature DB >> 32537269

Aspergillus and Rhizopus Fungal Coinfection in a Patient With Multiple Myeloma.

Anum Aqsa1, Sami Droubi1, Allison Glaser2.   

Abstract

Opportunistic fungal infections are rare but life-threatening in immunocompromised patients. We discuss a case of an immunocompromised patient with multiple myeloma who presented with shortness of breath, fever, ocular palsy, and hemiplegia. She was found to have influenza A respiratory tract infection complicated by invasive aspergillosis and mucormycosis. Investigation revealed invasive fungal sinusitis and cerebritis. Serum biomarkers, beta-d-glucan, and galactomannan failed to detect fungal disease. We believe that our case is unique as there is limited data available regarding the occurrence of invasive fungal infections after Influenza infections. Furthermore, it highlights the hurdles in the diagnosis of disseminated fungal infection.
Copyright © 2020, Aqsa et al.

Entities:  

Keywords:  aspergillus; influenza a; multiple myeloma; rhizopus

Year:  2020        PMID: 32537269      PMCID: PMC7286591          DOI: 10.7759/cureus.8050

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  14 in total

1.  Combined mucormycosis and Aspergillosis of the rhinocerebral region.

Authors:  Carmine Alfano; Stefano Chiummariello; Luca A Dessy; Giovanni Bistoni; Nicolò Scuderi
Journal:  In Vivo       Date:  2006 Mar-Apr       Impact factor: 2.155

2.  Perspectives in multiple myeloma: survival, prognostic factors and disease complications in a single centre between 1975 and 1988.

Authors:  H C Rayner; A P Haynes; J R Thompson; N Russell; J Fletcher
Journal:  Q J Med       Date:  1991-06

3.  Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.

Authors:  D A Stevens; V L Kan; M A Judson; V A Morrison; S Dummer; D W Denning; J E Bennett; T J Walsh; T F Patterson; G A Pankey
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

4.  Zygomycosis in the 1990s in a tertiary-care cancer center.

Authors:  D P Kontoyiannis; V C Wessel; G P Bodey; K V Rolston
Journal:  Clin Infect Dis       Date:  2000-06-13       Impact factor: 9.079

5.  Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002--Medical Research Council Adult Leukaemia Working Party.

Authors:  Bradley M Augustson; Gulnaz Begum; Janet A Dunn; Nicola J Barth; Faith Davies; Gareth Morgan; Judith Behrens; Alastair Smith; J Anthony Child; Mark T Drayson
Journal:  J Clin Oncol       Date:  2005-11-07       Impact factor: 44.544

Review 6.  Invasive pulmonary aspergillosis and influenza co-infection in immunocompetent hosts: case reports and review of the literature.

Authors:  Melisa M Shah; Eric I Hsiao; Carl M Kirsch; Amit Gohil; Supriya Narasimhan; David A Stevens
Journal:  Diagn Microbiol Infect Dis       Date:  2018-02-02       Impact factor: 2.803

7.  Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease.

Authors:  Sophia Koo; Julie M Bryar; John H Page; Lindsey R Baden; Francisco M Marty
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

Review 8.  Opportunistic invasive fungal infections: diagnosis & clinical management.

Authors:  Parisa Badiee; Zahra Hashemizadeh
Journal:  Indian J Med Res       Date:  2014-02       Impact factor: 2.375

9.  Case report: Disseminated aspergillosis complicating influenza.

Authors:  Shanan Immel; Edwin Yu
Journal:  Med Mycol Case Rep       Date:  2019-04-27

10.  Combined mucormycosis and aspergillosis of the oro-sinonasal region in a patient affected by Castleman disease.

Authors:  Eugenio Maiorano; Gianfranco Favia; Saverio Capodiferro; Maria Teresa Montagna; Lorenzo Lo Muzio
Journal:  Virchows Arch       Date:  2004-10-05       Impact factor: 4.535

View more
  2 in total

1.  Optimization of a Quantitative PCR Methodology for Detection of Aspergillus spp. and Rhizopus arrhizus.

Authors:  Alexandre Mendonça; Joana Carvalho-Pereira; Ricardo Franco-Duarte; Paula Sampaio
Journal:  Mol Diagn Ther       Date:  2022-06-16       Impact factor: 4.476

Review 2.  Mini Review: Risk Assessment, Clinical Manifestation, Prediction, and Prognosis of Mucormycosis: Implications for Pathogen- and Human-Derived Biomarkers.

Authors:  Jaime David Acosta-España; Kerstin Voigt
Journal:  Front Microbiol       Date:  2022-06-20       Impact factor: 6.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.